What is the return on Triochem Products Ltd (TRIPR) share?
The past returns of Triochem Products Ltd (TRIPR) share are- Past 1 week: N/A%
- Past 1 month: N/A%
- Past 3 months: N/A%
- Past 6 months: N/A%
- Past 1 year: N/A%
- Past 3 years: -100%
- Past 5 years: N/A%
What are the peers or stocks similar to Triochem Products Ltd (TRIPR)?
The peers or stocks similar to Triochem Products Ltd (TRIPR) include:What is the PE and PB ratio of Triochem Products Ltd (TRIPR) stock?
The P/E (price-to-earnings) ratio of Triochem Products Ltd (TRIPR) is N/A. The P/B (price-to-book) ratio is N/A.Which sector does Triochem Products Ltd (TRIPR) belong to?
Triochem Products Ltd (TRIPR) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Triochem Products Ltd (TRIPR) shares?
You can directly buy Triochem Products Ltd (TRIPR) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Triochem Products Ltd
TRIPR Share Price
0.00100.00% (-17.40)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TRIPR Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TRIPR Performance & Key Metrics
TRIPR Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 0 | 0 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.15 | 6.59 | 0.81% |
TRIPR Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
TRIPR Company Profile
Triochem Products Limited is engaged in the manufacturing of chemical substances that are used in the manufacture of pharmaceuticals. The Company manufactures and exports pharmaceutical bulk drugs, active pharmaceutical ingredients and chemicals.
SUNPHARMA
PE Ratio
36.80
36.80
1Y Return
7.60%
7.60%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.18
23.18
1Y Return
2.20%
2.20%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
59.65
59.65
1Y Return
17.34%
17.34%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
19.24
19.24
1Y Return
0.89%
0.89%
Buy Reco %
55.17
55.17
ZYDUSLIFE
PE Ratio
22.26
22.26
1Y Return
11.97%
11.97%
Buy Reco %
44.44
44.44
TRIPR Forecast
TRIPR Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
TRIPR
TRIPR
Income
Balance Sheet
Cash Flow
Annual Normal View
TRIPR Income Statement
TRIPR Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 18.22 | 35.40 | 12.41 | 20.50 | 14.07 | 9.38 | 0.28 | 1.03 | 1.05 | 1.28 | ||||||||||
Raw Materials | 16.71 | 28.76 | 11.55 | 10.06 | 12.48 | 5.51 | 0.00 | 0.00 | 0.05 | 1.53 | ||||||||||
| Power & Fuel Cost | 0.53 | 0.75 | 0.61 | 0.41 | 0.43 | 0.25 | 0.29 | 0.29 | 0.36 | |||||||||||
| Employee Cost | 0.68 | 0.73 | 0.72 | 0.82 | 0.67 | 0.50 | 0.52 | 0.47 | 0.59 | |||||||||||
| Selling & Administrative Expenses | 0.21 | 0.26 | 0.20 | 0.17 | 0.26 | 0.14 | 0.18 | 0.15 | 0.15 | |||||||||||
| Operating & Other expenses | -1.07 | 0.69 | -2.38 | 4.02 | 0.47 | 1.09 | 0.35 | 1.36 | 0.07 | |||||||||||
EBITDA | 1.16 | 4.21 | 1.71 | 5.02 | -0.24 | 1.89 | -1.06 | -1.24 | -0.17 | -0.25 | ||||||||||
| Depreciation/Amortization | 0.28 | 0.25 | 0.21 | 0.17 | 0.14 | 0.12 | 0.11 | 0.09 | 0.08 | 0.10 | ||||||||||
| PBIT | 0.88 | 3.96 | 1.50 | 4.85 | -0.38 | 1.77 | -1.17 | -1.33 | -0.25 | -0.35 | ||||||||||
| Interest & Other Items | 0.07 | 0.40 | 0.46 | 0.30 | 0.21 | 0.02 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | 0.81 | 3.56 | 1.04 | 4.55 | -0.59 | 1.75 | -1.17 | -1.33 | -0.25 | -0.35 | ||||||||||
| Taxes & Other Items | 0.23 | 1.02 | 0.30 | 1.15 | -0.14 | 0.44 | -0.29 | -0.32 | 0.15 | 0.14 | ||||||||||
| Net Income | 0.58 | 2.54 | 0.74 | 3.40 | -0.45 | 1.31 | -0.88 | -1.01 | -0.40 | -0.49 | ||||||||||
| EPS | 23.67 | 103.67 | 30.20 | 138.78 | -18.37 | 53.47 | -35.92 | -41.22 | -16.33 | -20.00 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
TRIPR Company Updates
TRIPR Stock Peers
TRIPR Past Performance & Peer Comparison
TRIPR Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Triochem Products Ltd | 0.00 | 0.00 | — |
| Sun Pharmaceutical Industries Ltd | 36.80 | 5.99 | 0.95% |
| Cipla Ltd | 23.18 | 3.91 | 1.06% |
| Torrent Pharmaceuticals Ltd | 59.65 | 16.63 | 0.95% |
TRIPR Stock Price Comparison
Compare TRIPR with any stock or ETFCompare TRIPR with any stock or ETF
TRIPR
TRIPR Holdings
TRIPR Shareholdings
TRIPR Promoter Holdings Trend
TRIPR Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
TRIPR Institutional Holdings Trend
TRIPR Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TRIPR Shareholding Pattern
TRIPR Shareholding Pattern
TRIPR Shareholding History
TRIPR Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing TRIPR stock
smallcases containing TRIPR stock
Looks like this stock is not in any smallcase yet.
TRIPR Events
TRIPR Events
TRIPR Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TRIPR has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TRIPR Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TRIPR has not given any dividends in last 5 years
TRIPR Dividends
TRIPR Dividends
Hmm, looks like data is unavailable here. Please come back after some timeTRIPR Stock News & Opinions
TRIPR Stock News & Opinions
Articles & Videos
Corporate
Triochem Products AGM scheduled
Triochem Products announced that the 53th Annual General Meeting(AGM) of the company will be held on 25 June 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Triochem Products reports standalone net loss of Rs 0.45 crore in the March 2025 quarter
Net loss of Triochem Products reported to Rs 0.45 crore in the quarter ended March 2025 as against net profit of Rs 0.32 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.40 crore in the year ended March 2025 as against net loss of Rs 1.01 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Triochem Products to announce Quarterly Result
Triochem Products will hold a meeting of the Board of Directors of the Company on 24 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Triochem Products to hold board meeting
Triochem Products will hold a meeting of the Board of Directors of the Company on 28 March 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Triochem Products to hold board meeting
Triochem Products will hold a meeting of the Board of Directors of the Company on 21 March 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Triochem Products reports standalone net profit of Rs 0.09 crore in the December 2024 quarter
Net profit of Triochem Products reported to Rs 0.09 crore in the quarter ended December 2024 as against net loss of Rs 0.20 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Triochem Products to conduct board meeting
Triochem Products will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Triochem Products reports standalone net loss of Rs 0.04 crore in the September 2024 quarter
Net Loss of Triochem Products reported to Rs 0.04 crore in the quarter ended September 2024 as against net loss of Rs 1.03 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Triochem Products to table results
Triochem Products will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Triochem Products reports standalone net loss of Rs 0.08 crore in the June 2024 quarter
Net Loss of Triochem Products reported to Rs 0.08 crore in the quarter ended June 2024 as against net loss of Rs 0.11 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -44.81%, vs industry avg of 10.14%
Over the last 5 years, market share decreased from 0.01% to 0%